Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lenograstim
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lenograstim 33.6million unit inj pre-filled syringes
0901060K0AAADAD
|
Lenograstim | Lenograstim | Nutrition and Blood | 7 |
|
Granocyte 13million unit inj pre-filled syringes
0901060K0BBAEAC
|
Granocyte | Lenograstim | Nutrition and Blood | 3 |
|
Lenograstim 13.4million unit inj pre-filled syringes
0901060K0AAACAC
|
Lenograstim | Lenograstim | Nutrition and Blood | 2 |
|
Granocyte 13million unit inj vials
0901060K0BBADAB
|
Granocyte | Lenograstim | Nutrition and Blood | No data available |
|
Granocyte 34million unit inj pre-filled syringes
0901060K0BBAFAD
|
Granocyte | Lenograstim | Nutrition and Blood | No data available |
|
Granocyte 34million unit inj vials
0901060K0BBACAA
|
Granocyte | Lenograstim | Nutrition and Blood | No data available |
|
Lenograstim 13.4million unit inj vials
0901060K0AAABAB
|
Lenograstim | Lenograstim | Nutrition and Blood | No data available |
|
Lenograstim 33.6million unit inj vials
0901060K0AAAAAA
|
Lenograstim | Lenograstim | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.